Researchers discovered that patients taking new GLP-1 weight-loss medications experienced reduced cravings along with a lower susceptibility to addiction. For individuals with existing substance use disorders, the risk of overdose dropped by 39%, and deaths linked to addiction were cut in half. These effects, seen across different addictive substances, were unprecedented for some of them.
Weight-loss drug shows promise to treat addictions
NATIONAL GEOGRAFIC


